IMCC Company Profile and Key Details

IMCC has shown weak momentum, losing -6.59% over the past week and -19.59% over the past quarter, though year-to-date performance is down -33.05%. Short-term trend indicators are mixed aligned (SMA20 -6.22%, SMA50 -2.12%, SMA200 -24.52%). The stock’s 14-day RSI is 47.9 (neutral), while the ATR of 0.24 points to higher daily volatility. The stock remains hovering near 52-week lows, trading -78.09% below its high and over 67.74% above its low. Average 10-day trading volume of 874.14 thousand shares is significantly above the 3-month average of 536.03 thousand, indicating heightened recent market interest.

IM Cannabis Corp. generated EPS of -$0.79 over the past year. Five-year average earnings growth is 20.43%. The latest quarter delivered EPS of -$0.54. The next quarter is forecast at $nan. Next year's EPS is expected at $60.66. IM Cannabis Corp. earnings surprise history is frequent misses against expectations. The quarter that ended November 13, 2025, missed forecasts by 2214.35%. The prior quarter beat by -48.79%. Over the last six quarters, Apple has recorded several small beats. These include -79.76% in August 14, 2024.

IM Cannabis Corp. (NASDAQ:IMCC) closed at $1.52 USD, losing -$0.04 (-2.24%) from the previous close of $1.56. The stock is currently mid-range between its 52-week high and low $0.93 and $7.12. With a market capitalization of about $4.71 million, IM Cannabis Corp. is classified as a micro-cap and shows higher-than-market volatility (beta ~1.99). Key stats such as the average daily volume over the past year has been around 555.96 thousand shares, volume is running light vs its 52-week average. Headquartered in Tel Aviv, None, IM Cannabis Corp. operates in the Healthcare sector and the Drug Manufacturers - Specialty & Generic industry. Led by CEO Oren Shuster, the company employs approximately 95 people and listed since May 20, 2020. IM Cannabis Corp. engages in breeding, growing, and supply of medical cannabis products in Israel, Germany, and Canada.

IM Cannabis Corp. has 6.09 million shares outstanding. The public float is 2.49 million shares, elevated short interest at 0.06% of float. This equals 2.99 thousand shares. The short ratio is 0.04 days. Institutional investors hold 7.79% of the float. Insiders own 44.66%.

Dividend and splits history remains an important factor for investors monitoring long-term returns.

Our AI price prediction model suggests that IM Cannabis Corp. stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term. 2-Week Outlook: Projected increase of 9.62%, with price expected at $1.71 by January 02, 2026, within a range of $1.54 to $1.88 3-Month Outlook: Projected fall of -68.59%, reaching $0.49 by March 19, 2026, with a range of $0.35 to $0.62. 1-Year Outlook: Projected loss of -57.69%, with price at $0.66 by December 18, 2026, within a range of $0.00 to $0.00.

IM Cannabis Corp. (NASDAQ:IMCC) shares are down -33.05% year-to-date currently trading near 52-week highs band. Short-term momentum has been negative over the last quarter, despite recent volatility. Valuation shows IM Cannabis Corp. trading at a premium to the broader market with a P/E of -2.23. Analyst sentiment is bullish, with the majority of ratings in Buy territory and a mean price target of $8.00, suggesting 412.82% upside. Our AI forecast model points to short-term strength (9.62% over two weeks), a medium-term fall (-68.59% over three months), and a longer-term loss (-57.69% over one year), with expected trading ranges indicating moderate volatility.

IM Cannabis Corp. trades at a P/E ratio of -2.23, slightly below the S&P 500 average, with a price-to-sales ratio of 0.13 and a price-to-book ratio of 2.64 suggesting the stock is closer to book value. The P/FCF stands at -1.77, also below market averages.